Works matching IS 09024441 AND DT 2022 AND VI 108 AND IP 6

Results: 12

Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 518, doi. 10.1111/ejh.13763

By:

Kennedy, Megan;
O' Mahony, Brian;
Roche, Sheila;
McGowan, Mark;
Singleton, Evelyn;
Ryan, Kevin;
O' Connell, Niamh M.;
Pipe, Steven W.;
Lavin, Michelle;
O' Donnell, James S.;
Turecek, Peter L.;
Gormley, John

Publication type:

Article

Systematic review of hematuria and acute renal failure with tranexamic acid.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 510, doi. 10.1111/ejh.13762

By:

Lee, Stephanie G.;
Fralick, John;
Wallis, Christopher J. D.;
Boctor, Monica;
Sholzberg, Michelle;
Fralick, Michael

Publication type:

Article

Intracranial haemorrhage in AML patients.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 536, doi. 10.1111/ejh.13761

By:

Murphy, Philip;
Glavey, Siobhan;
Quinn, John

Publication type:

Article

Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75‐year‐olds newly diagnosed with multiple myeloma.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 532, doi. 10.1111/ejh.13760

By:

Pérez‐Persona, Ernesto;
Oiartzabal‐Ormategui, Itziar;
Herraez, Susana;
Menchaca, Carmen;
Cuevas‐Palomares, Laida;
Santamaría‐López, Ana;
Díez‐Angulo, Rosana;
Robles‐Castro, Diego;
de Miguel‐Sánchez, Carlos;
Gabilondo‐Jalón, Miren;
Pisón‐Herrero, Carlos;
Unamunzaga‐Cilaurren, Ariane;
Vega González‐Viñaspre, Ana;
Salcedo‐Cuesta, Laura;
Mendizabal‐Abad, Arantza;
Guinea de Castro, José María

Publication type:

Article

Persistent opioid use in patients with multiple myeloma post‐ASCT.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 503, doi. 10.1111/ejh.13759

By:

Danish, Matthew L.;
Shah, Mansi R.;
Lin, Yong;
Ho, Joseph K.;
Copeland, Tabitha M.;
Cooper, Dennis L.

Publication type:

Article

Investigating the utility of saliva immunoglobulins for the detection of myeloma and using myeloma proteins to clarify partition between oral and systemic immunity.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 493, doi. 10.1111/ejh.13758

By:

Heaney, Jennifer L. J.;
Faustini, Sian;
Evans, Lili;
Rapson, Alec;
Collman, Emily;
Emery, Annabelle;
Campbell, John P.;
Moore, Sally;
Goodall, Margaret;
Afzal, Zaheer;
Chapple, Iain L.;
Pratt, Guy;
Drayson, Mark T.

Publication type:

Article

Risk of multiple myeloma and other malignancies among first‐ and second‐degree relatives of patients with multiple myeloma: A population‐based study.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 486, doi. 10.1111/ejh.13757

By:

Langseth, Øystein O.;
Myklebust, Tor Å.;
Johannesen, Tom B.;
Hjertner, Øyvind;
Waage, Anders

Publication type:

Article

Antibody titers after SARS‐CoV‐2 mRNA vaccination in patients with aplastic anemia—A single‐center study.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 528, doi. 10.1111/ejh.13756

By:

Walter, Jeanette;
Kricheldorf, Kim;
Isfort, Susanne;
Brümmendorf, Tim H.;
Panse, Jens;
Beier, Fabian

Publication type:

Article

Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 469, doi. 10.1111/ejh.13755

By:

Vu, Martin;
Degeling, Koen;
Thompson, Ella R.;
Blombery, Piers;
Westerman, David;
IJzerman, Maarten J.

Publication type:

Article

Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 460, doi. 10.1111/ejh.13754

By:

Keegan, Anastazia;
Dennington, Peta M.;
Dhondy, Nina;
Mulligan, Stephen P.

Publication type:

Article

Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 449, doi. 10.1111/ejh.13753

By:

Papayannidis, Cristina;
Nanni, Jacopo;
Cristiano, Gianluca;
Marconi, Giovanni;
Sartor, Chiara;
Parisi, Sarah;
Zannoni, Letizia;
Saed, Rashed;
Ottaviani, Emanuela;
Bandini, Lorenza;
Testoni, Nicoletta;
Baldazzi, Carmen;
Solli, Vincenza;
Ricci, Paolo;
Di Giovanni Bezzi, Chiara;
Abd‐alatif, Rania;
Stanzani, Marta;
Paolini, Stefania;
Cavo, Michele;
Curti, Antonio

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2022, v. 108, n. 6, p. 447, doi. 10.1111/ejh.13656
Publication type:: Article